Karin A. Oien

23.9k total citations
64 papers, 3.6k citations indexed

About

Karin A. Oien is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Karin A. Oien has authored 64 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 13 papers in Surgery and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Karin A. Oien's work include Pancreatic and Hepatic Oncology Research (19 papers), Oral and Maxillofacial Pathology (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Karin A. Oien is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Oral and Maxillofacial Pathology (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Karin A. Oien collaborates with scholars based in United Kingdom, United States and Netherlands. Karin A. Oien's co-authors include Nigel B. Jamieson, Colin J. McKay, Owen J. Sansom, Jennifer P. Morton, T.R. Jeffry Evans, Jayne L. Dennis, Donald C. McMillan, Dimitris Athineos, Brendan Doyle and Margaret C. Frame and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Cell Biology.

In The Last Decade

Karin A. Oien

61 papers receiving 3.5k citations

Peers

Karin A. Oien

ONCOL

SURGE

PFM

Aziza Nassar United States

Wentao Yang China

David N. Church United Kingdom

Yun Gong United States

Thaer Khoury United States

Soomin Ahn South Korea

Carolien H. M. van Deurzen Netherlands

Wolfgang Schmitt Germany

Giuliana Amaddeo France

Neda Kalhor United States

Aziza Nassar United States

Karin A. Oien

1.3k ×0.6

ONCOL

709 ×0.6

856 ×1.0

858 ×1.5

SURGE

579 ×1.0

PFM

Citations per year, relative to Karin A. Oien Karin A. Oien (= 1×) peers Aziza Nassar

Countries citing papers authored by Karin A. Oien

Since Specialization

Citations

This map shows the geographic impact of Karin A. Oien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin A. Oien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin A. Oien more than expected).

Fields of papers citing papers by Karin A. Oien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin A. Oien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin A. Oien. The network helps show where Karin A. Oien may publish in the future.

Co-authorship network of co-authors of Karin A. Oien

This figure shows the co-authorship network connecting the top 25 collaborators of Karin A. Oien. A scholar is included among the top collaborators of Karin A. Oien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin A. Oien. Karin A. Oien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wasan, Harpreet, Jiazhao Wang, Elaine McCartney, et al.. (2023). LBA100 CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes. Annals of Oncology. 34. S1339–S1339. 2 indexed citations

Kendall, Timothy J., Frances Turner, Prakash Ramachandran, et al.. (2023). An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nature Medicine. 29(11). 2939–2953. 35 indexed citations

Forrest, Ewan, et al.. (2021). Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. Journal of Clinical Pathology. 75(7). 498–502. 2 indexed citations

Young, Caroline, Jessica Lee, Mark J. Arends, et al.. (2019). Survey of UK histopathology consultants’ attitudes towards academic and molecular pathology. Journal of Clinical Pathology. 72(6). 399–405. 4 indexed citations

Oien, Karin A., Max Robinson, Nasir Rajpoot, et al.. (2019). The use of digital pathology and image analysis in clinical trials. The Journal of Pathology Clinical Research. 5(2). 81–90. 74 indexed citations

Macklin, Philip S., Nischalan Pillay, Jessica Lee, et al.. (2019). CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom. British Journal of Cancer. 121(9). 738–743. 3 indexed citations

Williams, Bethany, Jessica Lee, Karin A. Oien, & Darren Treanor. (2018). Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute’s CM-Path initiative. Journal of Clinical Pathology. 71(5). 463–466. 49 indexed citations

Jones, William E., et al.. (2017). Cancers of unknown primary diagnosed during hospitalization: a population-based study. BMC Cancer. 17(1). 85–85. 25 indexed citations

Ali, Asif, Sarah Bell, Alan Bilsland, et al.. (2015). 47P Investigating various thresholds as immunohistochemistry cut-offs for observer agreement. Annals of Oncology. 26. ix8–ix8. 8 indexed citations

10.

McGlynn, Liane M., Simon McCluney, Nigel B. Jamieson, et al.. (2015). SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients. PLoS ONE. 10(6). e0131344–e0131344. 51 indexed citations

11.

Denley, S, Nigel B. Jamieson, Karin A. Oien, et al.. (2013). Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 17(5). 887–898. 79 indexed citations

12.

Yu, Xinzi, Tobias Zech, Laura McDonald, et al.. (2012). N-WASP coordinates the delivery and F-actin–mediated capture of MT1-MMP at invasive pseudopods. The Journal of Cell Biology. 199(3). 527–544. 138 indexed citations

13.

Jamieson, Nigel B., Karin A. Oien, Alan K. Foulis, et al.. (2012). The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 19(11). 3581–3590. 55 indexed citations

14.

Jamieson, Nigel B., Jennifer P. Morton, Asif Ali, et al.. (2011). MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 18(2). 534–545. 175 indexed citations

15.

Jamieson, Nigel B., et al.. (2011). Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Clinical Cancer Research. 17(10). 3316–3331. 103 indexed citations

16.

Jamieson, Nigel B., Alan K. Foulis, Karin A. Oien, et al.. (2010). Peripancreatic Fat Invasion Is an Independent Predictor of Poor Outcome Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 15(3). 512–524. 28 indexed citations

17.

Morton, Jennifer P., Paul Timpson, Saadia A. Karim, et al.. (2009). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proceedings of the National Academy of Sciences. 107(1). 246–251. 465 indexed citations

18.

Dennis, Jayne L., Torgeir R. Hvidsten, Ernst C. Wit, et al.. (2005). Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm. Clinical Cancer Research. 11(10). 3766–3772. 225 indexed citations

19.

Gaya, Daniel R., Karin A. Oien, Adrian J. Stanley, & Allan J. Morris. (2005). Bleeding gastric varices and antiphospholipid syndrome. Nature Clinical Practice Gastroenterology & Hepatology. 2(3). 156–159. 4 indexed citations

20.

Forrest, Ewan, et al.. (2002). Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha. Liver International. 22(4). 317–320. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact